tm logo
SIDEWINDER THERAPEUTICS
Live/Pending
NON-FINAL ACTION - MAILED

final action

on 05 Aug 2024

Last Applicant/ Owned by

9880 Campus Point Drive, Suite 360

San Diego

CA

92121

Serial Number

98307987 filed on 11th Dec 2023

Registration Number

N/A

Correspondent Address

Aaron D. Hendelman

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI

Palo Alto, CA 94304

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SIDEWINDER THERAPEUTICS

pharmaceutical and biological preparations for the treatment and prevention of diseases in humans, namely, cardiovascular disease, epilepsy, mitochondrial disease, central nervous system disease, infectious disease, acute respiratory disease, and rare diseases; pharmaceutical preparations, namely, a drug formulation for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hem Read More

Classification Information


Class [005]
Pharmaceutical Products


pharmaceutical and biological preparations for the treatment and prevention of diseases in humans, namely, cardiovascular disease, epilepsy, mitochondrial disease, central nervous system disease, infectious disease, acute respiratory disease, and rare diseases; pharmaceutical preparations, namely, a drug formulation for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, oncology, infectiology, and psychiatry; pharmaceutical preparations, namely, a drug formulation for use in pediatric, geriatric, emergency, family, and psychiatry; pharmaceutical preparations for the treatment of infectious and hereditary diseases; pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with the muscular system, the skeletal system, the cardiovascular system, the central nervous system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, and the integumentary system; pharmaceutical preparations for the treatment or prevention of muscle loss, metabolic conditions and diseases, gastrointestinal conditions and diseases, neurological conditions and diseases, cancer, osteoporosis, inflammatory conditions and diseases, genetic conditions and diseases, muscle diseases and disorders, hepatic conditions and diseases, fibrosis, malnutrition, atrophic diseases and conditions, epilepsy, sarcopenia, myopathies, neuropathies, neurodegenerative diseases, traumatic brain injury, concussion, movement disorders, dystrophies, anemias, and orphan diseases; pharmaceutical and biological preparations, namely, precision therapeutics; pharmaceutical and biological preparations, namely, large molecule precision therapeutics


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98307987

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 65440-TM1001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
07th Aug 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
07th Aug 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
05th Aug 2024NON-FINAL ACTION E-MAILED
05th Aug 2024NON-FINAL ACTION WRITTEN
05th Aug 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
10th Jul 2024ASSIGNED TO EXAMINER
11th Mar 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11th Dec 2023NEW APPLICATION ENTERED